Literature DB >> 19591006

Clinical parameters linked with malignancy in endometrial polyps.

O Gregoriou1, S Konidaris, N Vrachnis, K Bakalianou, N Salakos, K Papadias, A Kondi-Pafiti, G Creatsas.   

Abstract

AIM: To investigate the association of different clinical parameters with the histological diagnosis and the prevalence of premalignant and malignant endometrial polyps.
METHOD: The study included 516 cases from January 2002 to December 2006. Possible risk factors such as age, menopause status, abnormal bleeding, obesity, hypertension, diabetes mellitus, hormone therapy, use of tamoxifen and size of polyp were investigated in relation to their association with the malignant potential of endometrial polyps.
RESULTS: All cases of endometrial polyps underwent hysteroscopic resection; 96.9% of the cases were benign, 1.2% premalignant and 1.9% malignant. Premalignant and malignant endometrial polyps were significantly associated with advanced age (>60 years), menopause, obesity and diabetes. The malignant polyps were analyzed to eight endometrioid, one serous and one clear cell carcinoma.
CONCLUSION: The prevalence of premalignant and malignant endometrial polyps is very low. Advanced age, menopause, obesity and diabetes increase the risk of endometrial polyp malignancy.

Entities:  

Mesh:

Year:  2009        PMID: 19591006     DOI: 10.1080/13697130902912605

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  7 in total

1.  Risk Factors Associated with the Malignant Changes of Symptomatic and Asymptomatic Endometrial Polyps in Premenopausal Women.

Authors:  Amr K Elfayomy; Badeea S Soliman
Journal:  J Obstet Gynaecol India       Date:  2014-06-01

2.  Thickness of preperitoneal fat as a predictor of malignancy in overweight and obese women with endometrial polyps.

Authors:  Andrea Ciavattini; Jacopo DI Giuseppe; Nicolò Clemente; Lorenzo Moriconi; Giovanni Delli Carpini; Nina Montik; Laura Mazzanti
Journal:  Oncol Lett       Date:  2016-02-04       Impact factor: 2.967

3.  Premalignant lesions skew spleen cell responses to immune modulation by adipocytes.

Authors:  Silvana A Vielma; Richard L Klein; Corinne A Levingston; M Rita I Young
Journal:  Anticancer Res       Date:  2013-05       Impact factor: 2.480

4.  Concomitant p53 and PTEN immunoexpression to predict the risk of malignancy in endometrial polyps.

Authors:  Féres Abrão; Waldir Pereira Modotti; Daniel Spadoto-Dias; Flávia Neves Bueloni-Dias; Nilton José Leite; Gustavo Filipov Peres; Leonardo Vieira Elias; Maria Aparecida Custódio Domingues; Rogério Dias
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

5.  Premalignant and malignant lesions in endometrial polyps in patients undergoing hysteroscopic polypectomy.

Authors:  Marco Antonio Lenci; Vanessa Alessandra Lui do Nascimento; Ana Beatriz Grandini; Walid Makin Fahmy; Daniella de Batista Depes; Fausto Farah Baracat; Reginaldo Guedes Coelho Lopes
Journal:  Einstein (Sao Paulo)       Date:  2014 Jan-Mar

6.  Prevalence and predictors of atypical histology in endometrial polyps removed by hysteroscopy: A secondary analysis from the SICMIG hysteroscopy trial.

Authors: 
Journal:  Facts Views Vis Obgyn       Date:  2019-06

7.  Histopathological profile of women who had previously failed in-vitro fertilization and the association to the outcome in the subsequent in-vitro fertilization cycle.

Authors:  Naama Steiner; Rola F Turki; Waleed El-Khayat; Ghada Al Malki; Samer Tannus; Michael H Dahan
Journal:  Obstet Gynecol Sci       Date:  2021-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.